These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 529021)

  • 41. [Hepatic clearance of drugs. Physiological and pharmacokinetic considerations].
    Pellegrin P; Lesne M
    J Pharmacol; 1983; 14(2):107-39. PubMed ID: 6865443
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Studies on absorption and elimination of drugs.
    Ksiezyk M; Danek A
    Int J Clin Pharmacol; 1973 Nov; 8(3):222-7. PubMed ID: 4272488
    [No Abstract]   [Full Text] [Related]  

  • 43. Methodological aspects of the evaluation of the binding of drugs to plasma and tissue proteins.
    Tillement JP; Albengres E; Urien S
    Eur J Drug Metab Pharmacokinet; 1979; 4(3):123-7. PubMed ID: 393513
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pharmacokinetic aspects of drug metabolism.
    Gibaldi M
    Ann N Y Acad Sci; 1971 Jul; 179():19-31. PubMed ID: 4936775
    [No Abstract]   [Full Text] [Related]  

  • 45. Relationship of apparent systemic clearance to individual organ clearances: effect of pulmonary clearance and site of drug administration and measurement.
    Mehvar R
    Pharm Res; 1991 Mar; 8(3):306-12. PubMed ID: 2052516
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of plasma protein binding on clearance of drugs metabolized by Michaelis--Menten kinetics.
    Bachmann K; Sullivan TJ
    J Pharm Sci; 1982 Mar; 71(3):374-5. PubMed ID: 7069607
    [No Abstract]   [Full Text] [Related]  

  • 47. A pocket calculator program for pharmacokinetic dosing of drugs exhibiting single compartment first-order elimination and zero-order or first-order absorption.
    Hochstrasser DF; Fleck RJ; Hull JH; Sarubbi FA
    Comput Biomed Res; 1984 Feb; 17(1):27-37. PubMed ID: 6546538
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pharmacokinetics in the elderly.
    Crooks J; O'Malley K; Stevenson IH
    Clin Pharmacokinet; 1976; 1(4):280-96. PubMed ID: 797500
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Critical analysis of "flip-flop" phenomenon in two-compartment pharmacokinetic model.
    Byron PR; Notari RE
    J Pharm Sci; 1976 Aug; 65(8):1140-4. PubMed ID: 978432
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pharmacokinetics in renal failure.
    Nancarrow C; Mather LE
    Anaesth Intensive Care; 1983 Nov; 11(4):350-60. PubMed ID: 6359952
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [An electronic simulator for demonstration of pharmacokinetic concentration patterns].
    Bättig P
    Arzneimittelforschung; 1972 Mar; 22(3):603-6. PubMed ID: 5067940
    [No Abstract]   [Full Text] [Related]  

  • 52. Trend Analysis of a Database of Intravenous Pharmacokinetic Parameters in Humans for 1352 Drug Compounds.
    Lombardo F; Berellini G; Obach RS
    Drug Metab Dispos; 2018 Nov; 46(11):1466-1477. PubMed ID: 30115648
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pharmacodynamic principles of drug therapy in the aged.
    Bender AD
    J Am Geriatr Soc; 1974 Jul; 22(7):296-303. PubMed ID: 4841255
    [No Abstract]   [Full Text] [Related]  

  • 54. Some features of the kinetics and equilibrium of drug binding to plasma proteins.
    Berezhkovskiy LM
    Expert Opin Drug Metab Toxicol; 2008 Dec; 4(12):1479-98. PubMed ID: 19040325
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of saturable binding on the pharmacokinetics of drugs: a simulation.
    Oie S; Guentert TW; Tozer TN
    J Pharm Pharmacol; 1980 Jul; 32(7):471-7. PubMed ID: 6105182
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pharmacokinetic considerations in the haemodialysis of drugs.
    Parker PR; Parker WA
    J Clin Hosp Pharm; 1982 Jun; 7(2):87-99. PubMed ID: 7050183
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A comparison of pharmacokinetics between humans and monkeys.
    Akabane T; Tabata K; Kadono K; Sakuda S; Terashita S; Teramura T
    Drug Metab Dispos; 2010 Feb; 38(2):308-16. PubMed ID: 19910513
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Influence of administration route and blood sampling site on the area under the curve. Assessment of gut wall, liver, and lung metabolism from a physiological model.
    Klippert PJ; Noordhoek J
    Drug Metab Dispos; 1983; 11(1):62-6. PubMed ID: 6132799
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Drug interactions and clinical pharmacokinetics.
    Kristensen MB
    Clin Pharmacokinet; 1976; 1(5):351-72. PubMed ID: 797504
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Intravenous fentanyl kinetics.
    McClain DA; Hug CC
    Clin Pharmacol Ther; 1980 Jul; 28(1):106-14. PubMed ID: 7389247
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.